Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VanEck Biotech ETF (NQ:BBH)

245.36 +1.58 (+0.65%)
Official Closing Price Updated: 4:15 PM EDT, Sep 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,283
Open 245.36
Bid (Size) 231.30 (100)
Ask (Size) 259.25 (100)
Prev. Close 243.78
Today's Range 243.01 - 245.36
52wk Range 161.15 - 245.36
Shares Outstanding N/A
Dividend Yield 0.39%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? ↗
VanEck's concentrated 25-stock biotech portfolio surged 40.5% in one year, but Fidelity's diversified 365-holding fund delivered superior risk-adjusted returns with half the volatility. 
Via The Motley Fool
Topics ETFs
News headline image
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? ↗
PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper drawdowns. 
Via The Motley Fool
Topics ETFs

Performance

YTD
+29.0%
+29.0%
1 Month
+1.4%
+1.4%
3 Month
+20.4%
+20.4%
6 Month
+34.1%
+34.1%
1 Year
+51.3%
+51.3%

More News

Read More
News headline image
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals? ↗
Via The Motley Fool
Topics ETFs
PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? ↗
Via Stocktwits
News headline image
Which Biotech ETF Is a Better Buy: Concentrated Bet or Broad Basket? ↗
Via The Motley Fool
Topics ETFs
News headline image
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? ↗
Via The Motley Fool
Topics ETFs
News headline image
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026? ↗
Via The Motley Fool
Topics ETFs
News headline image
Vanguard Health Care ETF Outperforms VanEck Biotech on Returns, Yield, and Fees ↗
Via The Motley Fool
Topics ETFs
News headline image
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026? ↗
Via The Motley Fool
Topics ETFs
News headline image
IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now? ↗
Via The Motley Fool
Topics ETFs
News headline image
Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026? ↗
Via The Motley Fool
Topics ETFs
News headline image
Which is the Better Choice for Healthcare Investors? IYH or BBH? ↗
Via The Motley Fool
Topics ETFs
News headline image
BBH vs. XPH: Which Healthcare ETF Is Better for Beginners? ↗
Via The Motley Fool
Topics ETFs
News headline image
FHLC vs. BBH: Which Healthcare ETF Is the Better Buy? ↗
Via The Motley Fool
Topics ETFs
News headline image
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock ↗
Via Stocktwits
News headline image
Time For Gilead Sciences-Heavy ETFs? ↗
Via Talk Markets
News headline image
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention ↗
Via Benzinga
News headline image
VanEck Announces Year-End Distributions for VanEck Equity ETFs
From VanEck
Via Business Wire
News headline image
VanEck Announces Year-End Distributions for VanEck Equity ETFs
From VanEck
Via Business Wire
News headline image
VanEck Announces Year-End Distributions for VanEck Equity ETFs
From VanEck
Via Business Wire
News headline image
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules ↗
Via Benzinga
News headline image
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗
Via Benzinga
News headline image
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗
Via Benzinga
News headline image
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits ↗
Via Benzinga
News headline image
VanEck Launches Robotics ETF (IBOT)
From VanEck
Via Business Wire

Frequently Asked Questions

Is VanEck Biotech ETF publicly traded?
Yes, VanEck Biotech ETF is publicly traded.
What exchange does VanEck Biotech ETF trade on?
VanEck Biotech ETF trades on the Nasdaq Stock Market
What is the ticker symbol for VanEck Biotech ETF?
The ticker symbol for VanEck Biotech ETF is BBH on the Nasdaq Stock Market
What is the current price of VanEck Biotech ETF?
The current price of VanEck Biotech ETF is 245.36
When was VanEck Biotech ETF last traded?
The last trade of VanEck Biotech ETF was at 09/25/26 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.